malignant melanoma
Conditions
Interventions
We will perform surgery under general anesthesia. We inject Indocyanine Green (ICG) into the primary tumor of the limbs. We use lymphography to confirm sentinel lymph nodes and lymph flow. We conduct
Sponsors
Faculty of Life Sciences, Kumamoto University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The subject has malignant melanoma of the thigh or brachial primary, and has regional lymph node metastasis. The subject must be over 20 years old at the acquisition date. The subject can be determined to participate in the study at their own will.
Exclusion criteria
Exclusion criteria: Subjects have a history of severe hypersensitivity and side effects in Indocyanine green (ICG). Subjects suffer from malignant tumors within 5 years. Subjects suffer from acute myocardial infarction, unstable angina, myocarditis, cerebral infarction within 3 months. Subjects have remarkably unstable circulation dynamics due to severe heart failure, arrhythmia, etc. Subject has active infection. Subjects may be pregnant or pregnant Subject's serum albumin is less than 2g/dl. We can not identify lymph flow with ICG during surgery. In addition, when the doctor in charge judges the subject as inappropriate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Relapse-free survival | — |
Countries
Japan
Contacts
Public ContactJun Aoi
Faculty of Life Sciences, Kumamoto University Department of Dermatology and Plastic Surgery
Outcome results
None listed